SCM
UTHR icon

Sio Capital Management’s United Therapeutics UTHR Stock Holding History

Sio Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80,050
Closed -$17.6M – 58
2023
Q4 		$17.6M Sell
80,050
-1,556
-2% -$359K 4.01% 9
2023
Q3 		$18.4M Buy
81,606
+1,680
+2% +$387K 5.71% 4
2023
Q2 		$17.6M Buy
79,926
+4,923
+7% +$1.09M 4.49% 7
2023
Q1 		$16.8M Buy
75,003
+20,044
+36% +$4.94M 8.3% 5
2022
Q4 		$15.3M Buy
54,959
+10,000
+22% +$2.52M 5.65% 6
2022
Q3 		$9.41M Buy
44,959
+5,000
+13% +$1.12M 2.99% 13
2022
Q2 		$9.42M Sell
39,959
-15,303
-28% -$3.11M 3.54% 9
2022
Q1 		$9.91M Buy
55,262
+2,069
+4% +$394K 3.28% 11
2021
Q4 		$11.5M Sell
53,193
-5,953
-10% -$1.17M 3.47% 10
2021
Q3 		$10.9M Buy
59,146
+12,434
+27% +$2.45M 3.48% 10
2021
Q2 		$8.38M Sell
46,712
-9,332
-17% -$1.78M 2.08% 14
2021
Q1 		$9.37M Buy
56,044
+17,310
+45% +$2.89M 1.9% 14
2020
Q4 		$5.88M Sell
38,734
-20,476
-35% -$2.69M 1.2% 27
2020
Q3 		$5.98M Sell
59,210
-6,000
-9% -$658K 1.18% 28
2020
Q2 		$7.89M Sell
65,210
-25,613
-28% -$2.88M 2.3% 16
2020
Q1 		$8.61M Sell
90,823
-41,841
-32% -$3.98M 2.89% 12
2019
Q4 		$11.7M Buy
132,664
+45,000
+51% +$3.96M 2.78% 12
2019
Q3 		$6.99M Buy
87,664
+4,772
+6% +$384K 2.25% 15
2019
Q2 		$6.47M Buy
82,892
+49,237
+146% +$4.6M 1.56% 21
2019
Q1 		$3.95M Buy
33,655
+3,655
+12% +$426K 1.07% 39
2018
Q4 		$3.27M Buy
+30,000
New +$3.48M 1.19% 39
2016
Q2 		– Sell
-77,317
Closed -$8.62M – 54
2016
Q1 		$8.62M Buy
+77,317
New +$9.78M 3.15% 13
2015
Q4 		– Sell
-37,677
Closed -$4.95M – 48
2015
Q3 		$4.95M Buy
+37,677
New +$6.04M 3.39% 15
2015
Q2 		– Sell
-34,700
Closed -$5.98M – 47
2015
Q1 		$5.98M Buy
+34,700
New +$5.29M 3.4% 7

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sio Capital Management's UTHR Position: Q1 2024 in Review

Sio Capital Management sold out of United Therapeutics (UTHR) in Q1 2024, closing a stake of 80,050 shares — an estimated $17.6M sold.

Sio Capital Management first reported a position in UTHR in Q1 2015 and held it in 24 quarters. The position peaked at $18.4M in Q3 2023. 526 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Sio Capital Management reported no remaining United Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Sio Capital Management sold 80,050 United Therapeutics shares in Q1 2024, an estimated $17.6M.
  • Sio Capital Management first reported a position in United Therapeutics in Q1 2015 and held it in 24 quarters.
  • Sio Capital Management's United Therapeutics position peaked at $18.4M in Q3 2023.
  • 526 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Sio Capital Management's 13F filing for Q1 2024, filed 15 May 2024.